This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).
Eligibility
Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* • Age ≥ 21 years
* Vital teeth
* Sufficient tooth structure for veneer retention
* Willing and able to provide written informed consent
* Ability to attend all follow-up appointments
* Adequate oral hygiene as determined by the investigator
Exclusion Criteria:
* • Patients with active periodontal disease (probing depth \> 4mm, bleeding on probing)
* Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination)
* Poor oral hygiene (plaque index \> 30%)
* Pregnancy or nursing
* Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression)
* Known allergies to study materials (ceramic, or resin cement components)
* Inability to comply with study requirements
* Current participation in other dental clinical trials
* Active orthodontic treatment
Primary outcome measure(s)
Marginal discoloration — 18 months Measuring device: Modified USPHS criteria Alpha: No discoloration on margin Bravo: Discoloration found at margin Charlie: Discoloration with penetration in a pulpal direction
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.